1A. Fanning, N. Billo, T. Tannenbaum, et al. Engaging industrialized nations in the challenge to meet global targets. International Journal of Tuberculosis and Lung Disease,2004,7 (4) : 162.
2L. J. Veron, L. J. Blanc, M. Suchi et al. DOTS expansion : will we reach the 2005 targets?. International Journal of Tuberculosis and Lung Disease,2004,7 (2) :41.
3World Health Organization. Global tuberculosis control, WHO report, 2007, Geneva: WHO ,2007.
4T. S. Moulding, H. Q. Le, D. Rikleen, et al. Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin. International Journal of Tuberculosis and Lung Disease, 2004,7 (3) : 105 - 106.
5World Health Organization. The global plan to stop tuberculosis ,2006- 2015. Geneva: WHO, 2006.
6Y Balabanova, F Drobniewski, I Fedorin, et al. The Directly observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation. Respir Res,2006,7 ( 1 ) :44.
7Saeed Akhtar, Franklin White, Rumina Hasan, et al. Hyperendemic pulmonary tuberculosis in peri-urban areas of Karachi, Pakistan. BMC Public Health,2007,7:70.
4Masur H. Approach to the patient with human immunodeficiency virus infection: clinical features. In : Gorbaeh SL (eds) [ M ]. Infectious Disease. 2th Ed, London : W. B. Saunders, 1998 : 1052 - 1062.
5Girardi E, Palmieri F,Cingulani A,et al. Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antirctroviral therapy [J] .J Acquir Immune Defic Syndr,2001,26:326 - 331.
6Hutchison DCS,Drobniewski FA,Milburn HJ.Management of multiple drug-resistant tuberculosis [J].Respir Med,2003,97:65-70.
7Espinal MA,Laserson K,Camacho M,et al.Determinants of drug-resistant tuberculosios:analysis of 11 countries[J].Int J Tuberc Lung Dis,2001,5:887-893.
8Kritski AL,Rodrigues de Jesus LS,Andrade MK,et al.Retreatment tuberculosis cases.factors associated with drug resistance and adverse outcomes[J].Chest,1997,111:1162-1167.
9Wang PD,Lin RS.Drug-resistant tuberculosis in Taipai,1996-1999[J].Am J Infect Control,2001,29(1):41-47.
10Singla R,Al-Sharif N,Al-Sayegh MO,et al.Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh,Saudi Arabia[J].Int J Tuberc Lung Dis,2002,6(7):585-591.
